(Topline data full peer-reviewed publication pending.) Eli Lilly press release
The NTSB is urging other states to follow Utah
Effect of avenciguat on albuminuria in patients with CKD: two randomized placebo-controlled trials
Prescribers ordering these compounds from any pharmacy should document their clinical rationale carefully and inform patients of the regulatory status
There are lots of fad diets out there promising to help you drop the pounds, but the problem is that more often than not theyre very restrictive, which makes them hard to maintain in the long term
Reddy's, who said in a press release: "As the first company to receive market authorisation for generic semaglutide injection in Canada, we remain dedicated to expanding access to innovative, high-quality, affordable GLP-1 [glucagon-like peptide-1] treatments for patients with diabetes in the country" [Source: bmj.com/content/393/bmj-2026-597166]